AAAAAA

   
Results: 1-25 | 26-35
Results: 1-25/35
MORTALITY AND CANCER INCIDENCE OF AIRCRAFT MAINTENANCE WORKERS EXPOSED TO TRICHLOROETHYLENE AND OTHER ORGANIC-SOLVENTS AND CHEMICALS - EXTENDED FOLLOW-UP
Authors: BLAIR A HARTGE P STEWART PA MCADAMS M LUBIN J
Citation: A. Blair et al., MORTALITY AND CANCER INCIDENCE OF AIRCRAFT MAINTENANCE WORKERS EXPOSED TO TRICHLOROETHYLENE AND OTHER ORGANIC-SOLVENTS AND CHEMICALS - EXTENDED FOLLOW-UP, Occupational and environmental medicine, 55(3), 1998, pp. 161-171
THE APC 11307K ALLELE AND CANCER RISK IN A COMMUNITY-BASED STUDY OF ASHKENAZI JEWS
Authors: WOODAGE T KING SM WACHOLDER S HARTGE P STRUEWING JP MCADAMS M LAKEN SJ TUCKER MA BRODY LC
Citation: T. Woodage et al., THE APC 11307K ALLELE AND CANCER RISK IN A COMMUNITY-BASED STUDY OF ASHKENAZI JEWS, Nature genetics, 20(1), 1998, pp. 62-65
FINDINGS IN BENIGN OVARIES AT INCREASED RISK FOR DEVELOPING CARCINOMA
Authors: SHERMAN ME BURKS RT KURMAN RJ STRUEWING J LEE J HARTGE P
Citation: Me. Sherman et al., FINDINGS IN BENIGN OVARIES AT INCREASED RISK FOR DEVELOPING CARCINOMA, Modern pathology, 11(1), 1998, pp. 114-114
POPULATION-BASED STUDY OF RISK OF BREAST-CANCER IN CARRIERS OF BRCA2 MUTATION
Authors: THORLACIUS S STRUEWING JP HARTGE P OLAFSDOTTIR GH SIGVALDASON H TRYGGVADOTTIR L WACHOLDER S TULINIUS H EYFJORD JE
Citation: S. Thorlacius et al., POPULATION-BASED STUDY OF RISK OF BREAST-CANCER IN CARRIERS OF BRCA2 MUTATION, Lancet, 352(9137), 1998, pp. 1337-1339
CANCER RISK IN WOMEN EXPOSED TO DIETHYLSTILBESTROL IN-UTERO
Authors: HATCH EE PALMER JR TITUSERNSTOFF L NOLLER KL KAUFMAN RH MITTENDORF R ROBBOY SJ HYER M COWAN CM ADAM E COLTON T HARTGE P HOOVER RN
Citation: Ee. Hatch et al., CANCER RISK IN WOMEN EXPOSED TO DIETHYLSTILBESTROL IN-UTERO, JAMA, the journal of the American Medical Association, 280(7), 1998, pp. 630-634
THE KIN-COHORT STUDY FOR ESTIMATING PENETRANCE
Authors: WACHOLDER S HARTGE P STRUEWING JP PEE D MCADAMS M BRODY L TUCKER M
Citation: S. Wacholder et al., THE KIN-COHORT STUDY FOR ESTIMATING PENETRANCE, American journal of epidemiology, 148(7), 1998, pp. 623-630
DIFFERENTIATING DYSPLASTIC NEVI FROM MELANOMA - REPLY
Authors: TUCKER MA HARTGE P HALPERN A ELDER DE GERRY D CLARK WH HOLLY EA SAGEBIEL RW
Citation: Ma. Tucker et al., DIFFERENTIATING DYSPLASTIC NEVI FROM MELANOMA - REPLY, JAMA, the journal of the American Medical Association, 278(7), 1997, pp. 548-549
CLINICALLY RECOGNIZED DYSPLASTIC NEVI - A CENTRAL RISK FACTOR FOR CUTANEOUS MELANOMA
Authors: TUCKER MA HALPERN A HOLLY EA HARTGE P ELDER DE SAGEBIEL RW GUERRY D CLARK WH
Citation: Ma. Tucker et al., CLINICALLY RECOGNIZED DYSPLASTIC NEVI - A CENTRAL RISK FACTOR FOR CUTANEOUS MELANOMA, JAMA, the journal of the American Medical Association, 277(18), 1997, pp. 1439-1444
THE RISK OF CANCER-ASSOCIATED WITH SPECIFIC MUTATIONS OF BRCA1 AND BRCA2 AMONG ASHKENAZI JEWS
Authors: STRUEWING JP HARTGE P WACHOLDER S BAKER SM BERLIN M MCADAMS M TIMMERMAN MM BRODY LC TUCKER MA
Citation: Jp. Struewing et al., THE RISK OF CANCER-ASSOCIATED WITH SPECIFIC MUTATIONS OF BRCA1 AND BRCA2 AMONG ASHKENAZI JEWS, The New England journal of medicine, 336(20), 1997, pp. 1401-1408
ABORTION, BREAST-CANCER, AND EPIDEMIOLOGY
Authors: HARTGE P
Citation: P. Hartge, ABORTION, BREAST-CANCER, AND EPIDEMIOLOGY, The New England journal of medicine, 336(2), 1997, pp. 127-128
IMPORTANCE OF ALPHA-CAROTENE, BETA-CAROTENE, AND OTHER PHYTOCHEMICALSIN THE ETIOLOGY OF LUNG-CANCER
Authors: ZIEGLER RG COLAVITO EA HARTGE P MCADAMS MJ SCHOENBERG JB MASON TJ FRAUMENI JF
Citation: Rg. Ziegler et al., IMPORTANCE OF ALPHA-CAROTENE, BETA-CAROTENE, AND OTHER PHYTOCHEMICALSIN THE ETIOLOGY OF LUNG-CANCER, Journal of the National Cancer Institute, 88(9), 1996, pp. 612-615
NON-HODGKINS-LYMPHOMA AND SUNLIGHT
Authors: HARTGE P DEVESA SS GRAUMAN D FEARS TR FRAUMENI JF
Citation: P. Hartge et al., NON-HODGKINS-LYMPHOMA AND SUNLIGHT, Journal of the National Cancer Institute, 88(5), 1996, pp. 298-300
EPIDEMIOLOGY OF BRAIN LYMPHOMA AMONG PEOPLE WITH OR WITHOUT ACQUIRED-IMMUNODEFICIENCY-SYNDROME
Authors: COTE TR MANNS A HARDY CR YELLIN FJ HARTGE P LEMP G WEST D SINGLETON J YOUNG J KERNDT P DEAPEN D GINZBERG M ANTONCULVER H LIEB S HOPKINS R WILLIAMS B LIFF J MORGAN D PARKIN W
Citation: Tr. Cote et al., EPIDEMIOLOGY OF BRAIN LYMPHOMA AMONG PEOPLE WITH OR WITHOUT ACQUIRED-IMMUNODEFICIENCY-SYNDROME, Journal of the National Cancer Institute, 88(10), 1996, pp. 675-679
THE IMPORTANCE OF ALPHA-CAROTENE, BETA-CAROTENE, AND OTHER PHYTOCHEMICALS IN THE ETIOLOGY OF LUNG-CANCER
Authors: ZIEGLER RG COLAVITO EA HARTGE P MCADAMS MJ SCHOENBERG JB MASON TJ FRAUMENI JF
Citation: Rg. Ziegler et al., THE IMPORTANCE OF ALPHA-CAROTENE, BETA-CAROTENE, AND OTHER PHYTOCHEMICALS IN THE ETIOLOGY OF LUNG-CANCER, The FASEB journal, 10(3), 1996, pp. 1385-1385
VALIDATION STUDIES USING AN ALLOYED GOLD STANDARD - REPLY
Authors: WACHOLDER S HARTGE P ARMSTRONG B
Citation: S. Wacholder et al., VALIDATION STUDIES USING AN ALLOYED GOLD STANDARD - REPLY, American journal of epidemiology, 143(11), 1996, pp. 1176-1176
EFFECT OF HUMAN T-LYMPHOTROPIC VIRUS TYPE-I INFECTION ON NON-HODGKINS-LYMPHOMA INCIDENCE
Authors: CLEGHORN FR MANNS A FALK R HARTGE P HANCHARD B JACK N WILLIAMS E JAFFE E WHITE F BARTHOLOMEW C BLATTNER W
Citation: Fr. Cleghorn et al., EFFECT OF HUMAN T-LYMPHOTROPIC VIRUS TYPE-I INFECTION ON NON-HODGKINS-LYMPHOMA INCIDENCE, Journal of the National Cancer Institute, 87(13), 1995, pp. 1009-1014
NONDIFFERENTIAL MISCLASSIFICATION AND BIAS TOWARDS THE NULL - A CLARIFICATION
Authors: WACHOLDER S HARTGE P LUBIN JH DOSEMECI M
Citation: S. Wacholder et al., NONDIFFERENTIAL MISCLASSIFICATION AND BIAS TOWARDS THE NULL - A CLARIFICATION, Occupational and environmental medicine, 52(8), 1995, pp. 557-558
RECOGNITION AND CLASSIFICATION OF CLINICALLY DYSPLASTIC NEVI FROM PHOTOGRAPHS - A STUDY OF INTEROBSERVER VARIATION
Authors: HARTGE P HOLLY EA HALPERN A SAGEBIEL R GUERRY D ELDER D CLARK W HANSON L HARRISON C TARONE R TUCKER MA
Citation: P. Hartge et al., RECOGNITION AND CLASSIFICATION OF CLINICALLY DYSPLASTIC NEVI FROM PHOTOGRAPHS - A STUDY OF INTEROBSERVER VARIATION, Cancer epidemiology, biomarkers & prevention, 4(1), 1995, pp. 37-40
RATES AND RISKS OF OVARIAN-CANCER IN SUBGROUPS OF WHITE WOMEN IN THE UNITED-STATES - REPLY
Authors: HARTGE P
Citation: P. Hartge, RATES AND RISKS OF OVARIAN-CANCER IN SUBGROUPS OF WHITE WOMEN IN THE UNITED-STATES - REPLY, Obstetrics and gynecology, 85(2), 1995, pp. 320-320
RISE OF OVARIAN-CANCER AFTER TREATMENT FOR INFERTILITY
Authors: CRAMER DW HARTGE P NASCA PC WHITTEMORE AS
Citation: Dw. Cramer et al., RISE OF OVARIAN-CANCER AFTER TREATMENT FOR INFERTILITY, The New England journal of medicine, 332(19), 1995, pp. 1302-1302
OVARIAN-CANCER, OVULATION AND SIDE OF ORIGIN
Authors: HARTGE P DEVESA S
Citation: P. Hartge et S. Devesa, OVARIAN-CANCER, OVULATION AND SIDE OF ORIGIN, British Journal of Cancer, 71(3), 1995, pp. 642-643
VALIDATION STUDIES USING AN ALLOYED GOLD STANDARD - REPLY
Authors: WACHOLDER S HARTGE P DOSEMECI M ARMSTRONG B
Citation: S. Wacholder et al., VALIDATION STUDIES USING AN ALLOYED GOLD STANDARD - REPLY, American journal of epidemiology, 141(3), 1995, pp. 277-277
SUNLIGHT AND RISK OF UVEAL MELANOMA
Authors: HORN EP HARTGE P SHIELDS JA TUCKER MA
Citation: Ep. Horn et al., SUNLIGHT AND RISK OF UVEAL MELANOMA, Journal of the National Cancer Institute, 86(19), 1994, pp. 1476-1478
ASSOCIATIONS BETWEEN BLADDER-CANCER RISK-FACTORS AND TUMOR STAGE AND GRADE AT DIAGNOSIS
Authors: STURGEON SR HARTGE P SILVERMAN DT KANTOR AF LINEHAN WM LYNCH C HOOVER RN
Citation: Sr. Sturgeon et al., ASSOCIATIONS BETWEEN BLADDER-CANCER RISK-FACTORS AND TUMOR STAGE AND GRADE AT DIAGNOSIS, Epidemiology, 5(2), 1994, pp. 218-225
A SEARCH FOR DISEASES ASSOCIATED WITH HTLV-II AMONG GUAYMI PATIENTS, PANAMA
Authors: GIUSTI RM GRACIA F STEPHENS K FUKUDA K VITEK C HARTGE P LEVIN A BLATTNER W LEVINE P KAPLAN J
Citation: Rm. Giusti et al., A SEARCH FOR DISEASES ASSOCIATED WITH HTLV-II AMONG GUAYMI PATIENTS, PANAMA, AIDS research and human retroviruses, 10(4), 1994, pp. 447-447
Risultati: 1-25 | 26-35